Total Assets - EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 11.13 USD -0.27%

Updated:

EyePoint Pharmaceuticals Inc
Total Assets

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

EyePoint Pharmaceuticals Inc
Total Assets Peer Comparison

JNJ

BMY

PFE

MRK

LLY

Company		Total Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
	EyePoint Pharmaceuticals Inc NASDAQ:EYPT	Total Assets $329.2m	CAGR 3-Years 21%	CAGR 5-Years 32%	CAGR 10-Years 29%
	Johnson & Johnson NYSE:JNJ	Total Assets $172B	CAGR 3-Years 0%	CAGR 5-Years 3%	CAGR 10-Years 3%
	Bristol-Myers Squibb Co NYSE:BMY	Total Assets $99B	CAGR 3-Years -4%	CAGR 5-Years 23%	CAGR 10-Years 11%
	Pfizer Inc NYSE:PFE	Total Assets $221.1B	CAGR 3-Years 12%	CAGR 5-Years 7%	CAGR 10-Years 3%
	Merck & Co Inc NYSE:MRK	Total Assets $105.8B	CAGR 3-Years 5%	CAGR 5-Years 5%	CAGR 10-Years 0%
	Eli Lilly and Co NYSE:LLY	Total Assets $63.9B	CAGR 3-Years 11%	CAGR 5-Years 11%	CAGR 10-Years 6%

See Also

Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Total Assets amounts to 329.2m USD.

Over the last year, the Total Assets growth was 113%. The average annual Total Assets growth rates for EyePoint Pharmaceuticals Inc have been 21% over the past three years , 32% over the past five years , and 29% over the past ten years .

Join more than 141,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.